Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

BioArctic AB · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
parkinson-disease
parkinson disease, multiple system atrophy, exidavnemab, exist, ban-0805, abbv-0805, alfa-synuclein, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813402
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.